AI-powered tools like Merck’s Aiddison can accelerate drug identification and optimise design, cutting both costs and time to ...

The Investment Committee debate the Calls of the Day in two biotech names.

When he left his job at Merck, he wanted to use his chemical expertise ... was already underway. A modular robot in a transparent box glided back and forth, preparing to dispense minute doses ...

Women’s Month, and especially International Women’s Day on March 8, is a time to recognize the groundbreaking contributions ...

Discover the groundbreaking innovations of African-American electronics engineers who have shaped the world we live in today.

We knew these deals with Novo Nordisk and Merck and Pfizer and so on to support ... why don't we use robots?, Why don't we automate this? And the big challenge is there's just so much variability ...

Both Merck & Co. and Halozyme are holding their ground in a freshly unveiled patent dispute surrounding the New Jersey pharma’s under-the-skin version of its blockbuster cancer drug Keytruda.

Merck shares have been under pressure amid disappointing sales trends for its Gardasil HPV vaccine. The company's broader drug portfolio continues to perform well and is driving a strong earnings ...

Trial adjourned, new jury due to reconvene in September Kennedy helped organize litigation against Merck before HHS role Merck denies claims, cites scientific evidence supporting Gardasil safety ...

Biotech Halozyme Therapeutics believes the new version of Merck's blockbuster cancer drug Keytruda infringes on its patents, the Wall Street Journal reported on Wednesday (March 5, 2025), citing ...